Italian cheap trick allowing unapproved drugs is 'dangerous attack on innovation'
This article was originally published in Scrip
Executive Summary
Draft legislation proposed by the Italian Ministry of Health contains "a very dangerous attack on the foundation of innovative drugs", Riccardo Palmisano, executive vice-president of the Italian biotech industry association Assobiotec, has warned. Dr Palmisano told Scrip that he was concerned about a "misuse of the philosophy" of a piece of legislation designed to allow patients with rare and orphan diseases to access yet-to-be authorised medicines, where no other therapies were available.